Oral Agents and SARS-CoV-2 Vaccine Effectiveness against Severe COVID-19 Omicron Events in Patients Requiring Maintenance Dialysis.

Manley, Harold J; Li, Nien Chen; Hsu, Caroline M; Weiner, Daniel E; Miskulin, Dana; Harford, Antonia M; Johnson, Doug; Lacson, Eduardo

Manley, Harold J; Li, Nien Chen; Hsu, Caroline M; Weiner, Daniel E; Miskulin, Dana; Harford, Antonia M; Johnson, Doug; Lacson, Eduardo.

Afiliação

Manley HJ; Dialysis Clinic Inc., Nashville, Tennessee.
Li NC; Dialysis Clinic Inc., Nashville, Tennessee.
Hsu CM; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
Weiner DE; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
Miskulin D; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
Harford AM; Dialysis Clinic Inc., Nashville, Tennessee.
Johnson D; Dialysis Clinic Inc., Nashville, Tennessee.
Lacson E; Dialysis Clinic Inc., Nashville, Tennessee.

Kidney360 ; 5(3): 445-450, 2024 Mar 01.

Article em En | MEDLINE | ID: mdl-38297444

Assuntos

Vacinas contra COVID-19; COVID-19; Humanos; COVID-19/prevenção & controle; SARS-CoV-2; Eficácia de Vacinas; Diálise Renal; Administração Oral

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: Kidney360 Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google